Published in Prog Clin Biol Res on January 01, 1988
Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest (1991) 3.62
Structure of the O-chain of the phenol-phase soluble cellular lipopolysaccharide of Yersinia enterocolitica serotype O:9. Eur J Biochem (1984) 3.16
Antigenic S-type lipopolysaccharide of Brucella abortus 1119-3. Infect Immun (1984) 3.10
Acute inflammation causes epithelial invasion and mucosal destruction in experimental shigellosis. J Exp Med (1994) 2.53
Interleukin 1 is released by murine macrophages during apoptosis induced by Shigella flexneri. J Clin Invest (1994) 2.47
Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit Care Med (1994) 2.01
Role of interleukin-1 in the pathogenesis of experimental shigellosis. J Clin Invest (1995) 1.67
Coupled plasma filtration-adsorption in a rabbit model of endotoxic shock. Crit Care Med (2000) 1.62
Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis. J Exp Med (1995) 1.54
The lipopolysaccharides of Brucella abortus and B. melitensis. Ann Inst Pasteur Microbiol (1987) 1.50
Dissociation between plasma and monocyte-associated cytokines during sepsis. Eur J Immunol (1991) 1.46
Mitochondrial membrane potential and apoptosis peripheral blood monocytes in severe human sepsis. Am J Respir Crit Care Med (2001) 1.41
NF-kappaB expression in mononuclear cells of patients with sepsis resembles that observed in lipopolysaccharide tolerance. Am J Respir Crit Care Med (2000) 1.41
Binding sites for endotoxins (lipopolysaccharides) on human monocytes. J Immunol (1991) 1.39
A novel granulocyte-derived peptide with lipopolysaccharide-neutralizing activity. J Immunol (1994) 1.39
Orthogonal time-of-flight secondary ion mass spectrometric analysis of peptides using large gold clusters as primary ions. Rapid Commun Mass Spectrom (2004) 1.37
Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci, and lipopolysaccharide. Infect Immun (1994) 1.37
Characterization of the common antigenic lipopolysaccharide O-chains produced by Bordetella bronchiseptica and Bordetella parapertussis. FEMS Microbiol Lett (1992) 1.37
A novel type of endotoxin structure present in Bordetella pertussis. Isolation of two different polysaccharides bound to lipid A. Eur J Biochem (1978) 1.32
Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease. Eur Respir J (1999) 1.27
Biological activities of fragments derived from Bordetella pertussis endotoxin: isolation of a nontoxic, Shwartzman-negative lipid A possessing high adjuvant properties. Infect Immun (1980) 1.25
Polymyxin-B inhibition of LPS-induced interleukin-1 secretion by human monocytes is dependent upon the LPS origin. Mol Immunol (1986) 1.24
Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide. J Exp Med (1993) 1.22
Molecular requirement for interleukin 1 induction by lipopolysaccharide-stimulated human monocytes: involvement of the heptosyl-2-keto-3-deoxyoctulosonate region. Eur J Immunol (1986) 1.15
Lipopolysaccharide receptor on rabbit peritoneal macrophages. I. Binding characteristics. J Immunol (1982) 1.12
Trophic effect of human pericardial fluid on adult cardiac myocytes. Differential role of fibroblast growth factor-2 and factors related to ventricular hypertrophy. Circ Res (1997) 1.12
Interleukin 1 secretion by human monocytes stimulated by the isolated polysaccharide region of the Bordetella pertussis endotoxin. Mol Immunol (1984) 1.11
C3a(C3adesArg) induces production and release of interleukin 1 by cultured human monocytes. J Immunol (1987) 1.10
Administration of endotoxin associated with lipopolysaccharide tolerance protects mice against fungal infection. Infect Immun (2000) 1.10
Cytokine profiles of AIDS patients are similar to those of mice with disseminated Cryptococcus neoformans infection. Infect Immun (1999) 1.08
Variable estimates of cytokine levels produced by commercial ELISA kits: results using international cytokine standards. J Immunol Methods (1995) 1.07
Matrix implanted laser desorption ionization (MILDI) combined with ion mobility-mass spectrometry for bio-surface analysis. J Proteome Res (2005) 1.07
Idiotypic determinants of rabbit B- and T-derived lymphocytes. Immunol Rev (1977) 1.04
Enhanced sensitivity of tumor necrosis factor/lymphotoxin-alpha-deficient mice to Cryptococcus neoformans infection despite increased levels of nitrite/nitrate, interferon-gamma, and interleukin-12. J Infect Dis (1999) 1.03
Novel variation of lipid A structures in strains of different Yersinia species. FEBS Lett (2000) 1.02
Lipopolysaccharide-induced cytokine cascade and lethality in LT alpha/TNF alpha-deficient mice. Mol Med (1997) 1.01
Structure of a hexasaccharide proximal to the hydrophobic region of lipopolysaccharides present in Bordetella pertussis endotoxin preparations. Carbohydr Res (1994) 1.00
Reduced ex vivo interleukin-8 production by neutrophils in septic and nonseptic systemic inflammatory response syndrome. Blood (1998) 0.99
Human T cells and interleukin 4 inhibit the release of interleukin 1 induced by lipopolysaccharide in serum-free cultures of autologous monocytes. Eur J Immunol (1989) 0.99
Do endotoxins devoid of 3-deoxy-D-manno-2-octulosonic acid exist? Biochem Biophys Res Commun (1987) 0.99
Specific binding of endotoxin to human monocytes and mouse macrophages: serum requirement. Cell Immunol (1985) 0.98
Presence of high levels of leukocyte-associated interleukin-8 upon cell activation and in patients with sepsis syndrome. Infect Immun (1997) 0.98
Mice heterozygous for a deletion of the tumor necrosis factor-alpha and lymphotoxin-alpha genes: biological importance of a nonlinear response of tumor necrosis factor-alpha to gene dosage. Eur J Immunol (1997) 0.97
Direct microextraction and analysis of rough-type lipopolysaccharides by combined thin-layer chromatography and MALDI mass spectrometry. Anal Chem (2001) 0.96
Protection against invasion of the mouse pulmonary epithelium by a monoclonal IgA directed against Shigella flexneri lipopolysaccharide. Ann N Y Acad Sci (1994) 0.95
Immune mediators in cerebrospinal fluid during cryptococcosis are influenced by meningeal involvement and human immunodeficiency virus serostatus. J Infect Dis (2000) 0.95
Pyrogenicity and cytokine-inducing properties of Streptococcus pyogenes superantigens: comparative study of streptococcal mitogenic exotoxin Z and pyrogenic exotoxin A. Infect Immun (2001) 0.94
IL-10 and IL-4 synergize with TNF-alpha to induce IL-1ra production by human neutrophils. Cytokine (1996) 0.92
Selective induction of interleukin-1 receptor antagonist and interleukin-8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin). Eur J Immunol (1995) 0.92
Removal of cytokines and activated complement components in an experimental model of continuous plasma filtration coupled with sorbent adsorption. Nephrol Dial Transplant (1998) 0.90
Regulation by anti-inflammatory cytokines (IL-4, IL-10, IL-13, TGFbeta)of interleukin-8 production by LPS- and/ or TNFalpha-activated human polymorphonuclear cells. Mediators Inflamm (1996) 0.90
In vivo induction of interleukin-1 during hemodialysis. Kidney Int (1989) 0.89
Mitogenicity of streptococcal extracellular products and antagonism with concanavalin A. Immunol Lett (1982) 0.89
Alterations of the outer membrane composition in Escherichia coli lacking the histone-like protein HU. Proc Natl Acad Sci U S A (1997) 0.89
Inability of pyrogenic, purified Bordetella pertussis lipid A to induce interleukin-1 release by human monocytes. Infect Immun (1986) 0.89
Structural characterization of the lipids A of three Bordetella bronchiseptica strains: variability of fatty acid substitution. J Bacteriol (1997) 0.89
Comparison of lipids A of several Salmonella and Escherichia strains by 252Cf plasma desorption mass spectrometry. J Bacteriol (1993) 0.89
High levels of portal TNF-alpha during abdominal aortic surgery in man. Cytokine (1993) 0.89
Selective cytotoxicity of Clostridium perfringens delta toxin on rabbit leukocytes. Infect Immun (1982) 0.88
Ex vivo T-lymphocyte derived cytokine production in SIRS patients is influenced by experimental procedures. Shock (2000) 0.88
A sensitive, IL-2-independent, assay for IL-1. J Immunol Methods (1988) 0.88
Specific and cross-reacting monoclonal antibodies to Bordetella parapertussis and Bordetella bronchiseptica lipopolysaccharides. Microbiology (1994) 0.88
Elevated levels of circulating transforming growth factor-beta 1 in patients with the sepsis syndrome. Ann Intern Med (1996) 0.87
Polyclonal antibody-forming cell activation and immunomodulation of the in vitro immune response induced by streptococcal extracellular products. Cell Immunol (1983) 0.87
Influence of surgery on in-vitro cytokine production by human monocytes. Cytokine (1992) 0.87
Dissociation of cell-associated interleukin-1 (IL-1) and IL-1 release induced by lipopolysaccharide and lipid A. Infect Immun (1989) 0.87
Long-term-impaired expression of nuclear factor-kappa B and I kappa B alpha in peripheral blood mononuclear cells of trauma patients. J Leukoc Biol (2001) 0.86
Ganglioside identification on human monocyte membrane with Clostridium perfringens delta-toxin. J Leukoc Biol (1986) 0.86
Identification of 2-amino-6-O-(2-amino-2-deoxy-beta-D-glucopyranosyl)-2-deoxy-D-glucose as a major constituent of the hydrophobic region of the Bordetella pertussis endotoxin. Carbohydr Res (1983) 0.86
Structure of the lipid A of Bordetella hinzii ATCC 51730. Rapid Commun Mass Spectrom (2000) 0.86
Draft Genome Sequences of Bordetella hinzii and Bordetella trematum. Genome Announc (2013) 0.86
Cytokines and soluble cytokine receptors in pleural effusions from septic and nonseptic patients. Am J Respir Crit Care Med (1997) 0.85
Induction of interferon by streptococcus pyogenes extracellular products. Immunol Lett (1982) 0.85
Lipopolysaccharide-induced production of cytokines by bone marrow-derived macrophages: dissociation between intracellular interleukin 1 production and interleukin 1 release. Cytokine (1990) 0.85
Interleukin-1 induction by lipopolysaccharides: structural requirements of the 3-deoxy-D-manno-2-octulosonic acid (KDO). Mol Immunol (1989) 0.85
Cytokine production by murine cells activated by erythrogenic toxin type A superantigen of Streptococcus pyogenes. Immunobiology (1992) 0.85
Interleukin 8 production in whole blood assays: Is interleukin 10 responsible for the downregulation observed in sepsis? Cytokine (2000) 0.85
Dissociation between the interleukin 1-inducing capacity and Limulus reactivity of lipopolysaccharides from gram-negative bacteria. Cytokine (1990) 0.84
Epitopes of Bordetella pertussis lipopolysaccharides as potential markers for typing of isolates with monoclonal antibodies. Microbiology (1996) 0.83
Rabbit B spleen lymphocytes and T helper cells. I. Responsiveness to mitogens of B cell subpopulations of different sedimentation velocities and subpopulations bearing or lacking Fcgamma receptors. J Immunol (1979) 0.83
Correlation between the capacity to activate macrophages in vitro and the antitumor activity in vivo of lipopolysaccharides from different bacterial species. Immunobiology (1994) 0.83
Helicobacter mustelae lipid A structure differs from that of Helicobacter pylori. FEBS Lett (2001) 0.83
Molecular aspects of endotoxins relevant to their biological functions. Nephrol Dial Transplant (1999) 0.83
Involvement of the LPS receptor in the induction of interleukin-1 in human monocytes stimulated with endotoxins. Ann Inst Pasteur Immunol (1987) 0.83
Inhibition by gangliosides of the specific binding of lipopolysaccharide (LPS) to human monocytes prevents LPS-induced interleukin-1 production. Cell Immunol (1987) 0.82
252Cf-plasma desorption mass spectrometry of unmodified lipid A: fragmentation patterns and localization of fatty acids. Rapid Commun Mass Spectrom (1999) 0.82
Synthetic peptides that mimic the binding site of horseshoe crab antilipopolysaccharide factor. J Infect Dis (1994) 0.82
The role of serum in interleukin 1 production by human monocytes activated by endotoxins and their polysaccharide moieties. Immunol Lett (1985) 0.81
Human pro- and anti-inflammatory cytokine patterns induced by Streptococcus pyogenes erythrogenic (pyrogenic) exotoxin A and C superantigens. Infect Immun (1996) 0.81
[Role of bacterial polyclonal activators in autoimmunity]. Nouv Presse Med (1982) 0.81
Paradoxical priming effects of IL-10 on cytokine production. Int Immunol (1999) 0.81
Structural features involved in the mitogenic activity of Bordetella pertussis lipopolysaccharides for spleen cells of C3H/HeJ mice. FEMS Immunol Med Microbiol (1993) 0.80
Purification of rabbit B spleen cells by removal of adherent and of T cells. J Immunol Methods (1979) 0.80
Macrophage-dependent polyclonal activation of splenocytes by Bordetella pertussis endotoxin and its isolated polysaccharide and Lipid A regions. Cell Immunol (1982) 0.80
Interactions between rabbit B and T lymphocytes in mitogenic response to staphylococcal protein A. Cell Immunol (1981) 0.80